Elsen Carvalho - Odontoprev Director
| ODPV3 Stock | BRL 10.94 0.14 1.30% |
Director
Mr. Elsen Carvalho is Corporationrationrate Commercial Director, Member of the Executive Board of the Company. Mr. Elsen has a Bachelors degree in Economics from UFRJ, MBA in CoppeadUFRJ, and OMP program at the Harvard Business School. He has a wide experience in commercial strategies, with emphasis on prospecting, developing and expanding the portfolio of clients. He has worked at Lojas Americanas, Unibanco, Banco Bozano and Invent. He was a partner, commercial director and member of the Investment Committee of Investidor Profissional . Mr. Elsen also worked at Archipelago Partners, where he was a founder, partner and member of the Investment Committee. since 2017.
| Age | 46 |
| Tenure | 7 years |
| Phone | 55 80 0702 9000 |
| Web | https://www.odontoprev.com.br |
Odontoprev Management Efficiency
The company has return on total asset (ROA) of 0.1998 % which means that it generated a profit of $0.1998 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3778 %, meaning that it generated $0.3778 on every $100 dollars invested by stockholders. Odontoprev's management efficiency ratios could be used to measure how well Odontoprev manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 11 records | DIRECTOR Age | ||
| Claudio Prado | Fleury SA | 55 | |
| Maria Lacerda | Hypera SA | 47 | |
| Andrea Chamma | Fleury SA | N/A | |
| Esteban Fomperosa | Hypera SA | 70 | |
| Jose Araujo | Fleury SA | N/A | |
| David Coury | Hypera SA | 63 | |
| Alvado Link | Hypera SA | 48 | |
| Samuel Santos | Fleury SA | 73 | |
| Bernardo Hernandez | Hypera SA | 54 | |
| Edgar Rizzatti | Fleury SA | N/A | |
| Jeane Tsutsui | Fleury SA | N/A | |
Management Performance
Odontoprev SA Leadership Team
Elected by the shareholders, the Odontoprev's board of directors comprises two types of representatives: Odontoprev inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Odontoprev. The board's role is to monitor Odontoprev's management team and ensure that shareholders' interests are well served. Odontoprev's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Odontoprev's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eduardo Toledo, Independent Director | ||
| Octavio Lazari, Director | ||
| Luis Blanco, Chief Administrative and Finance Officer, Member of the Executive Board | ||
| Luiz Cappi, Chairman of the Board | ||
| Ivan Gontijo, Director | ||
| Cesar Santos, Independent Director | ||
| Jose Benozatti, Clinical and Operating Officer, Member of the Executive Board | ||
| Renato Costa, Corporate Officer | ||
| Elsen Carvalho, Corporate Commercial Director, Member of the Executive Board | ||
| Rodrigo Wuerkert, Chief Executive Officer | ||
| Rose Gabay, Chief Human Resource Officer, Member of the Executive Board | ||
| Jose Pacheco, Investor Relations Officer, Member of the Executive Board | ||
| Samuel Santos, Director | ||
| Rodrigo Bacellar, Chief Officer | ||
| Murilo Passos, Independent Director | ||
| Jos Pacheco, Investor CFO | ||
| Vinicius Albernaz, Director | ||
| Stella Hong, IR Supervisor | ||
| Manoel Peres, Vice Chairman of the Board | ||
| Marcos Viveiros, Corporate Director |
Odontoprev Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Odontoprev a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.38 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 4.38 B | |||
| Shares Outstanding | 552.5 M | |||
| Shares Owned By Insiders | 51.40 % | |||
| Shares Owned By Institutions | 32.47 % | |||
| Price To Earning | 12.84 X | |||
| Price To Book | 3.89 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Odontoprev Stock Analysis
When running Odontoprev's price analysis, check to measure Odontoprev's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Odontoprev is operating at the current time. Most of Odontoprev's value examination focuses on studying past and present price action to predict the probability of Odontoprev's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Odontoprev's price. Additionally, you may evaluate how the addition of Odontoprev to your portfolios can decrease your overall portfolio volatility.